1. Academic Validation
  2. U18666A inhibits classical swine fever virus replication through interference with intracellular cholesterol trafficking

U18666A inhibits classical swine fever virus replication through interference with intracellular cholesterol trafficking

  • Vet Microbiol. 2019 Nov;238:108436. doi: 10.1016/j.vetmic.2019.108436.
Xiao-Dong Liang 1 Yun-Na Zhang 1 Chun-Chun Liu 1 Jing Chen 1 Xiong-Nan Chen 1 Abdul Sattar Baloch 1 Bin Zhou 2
Affiliations

Affiliations

  • 1 MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
  • 2 MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China. Electronic address: zhoubin@njau.edu.cn.
Abstract

The level of Cholesterol in host cells has been demonstrated to affect viral Infection. Our previous studies showed that cholesterol-rich membrane rafts mediated the entry of classical swine fever virus (CSFV) into PK-15 or 3D4/21 cells, but the role of Cholesterol post entry was still not clear. In this study, we found that CSFV replication before fusion was affected when the Cholesterol trafficking in infected cells was disrupted using a Cholesterol transport inhibitor, U18666A. Our data showed that U18666A affected both the fusion and replication steps in the life cycle of the virus, but not its binding and entry steps. The subsequent experiments confirmed that niemann-pick C1 (NPC1), a lysosomal membrane protein that helps Cholesterol to leave the lysosome, was affected by U18666A, which led to the accumulation of Cholesterol in lysosomes and inhibition of CSFV replication. Imipramine, a cationic hydrophobic amine similar to U18666A, also inhibited CSFV replication via similar mechanism. Surprisingly, the Antiviral effect of U18666A was restored by the histone deacetylase inhibitor (HDACi), Vorinostat, which suggested that HDACi reverted the dysfunction of NPC1, and intra-cellular Cholesterol accumulation disappeared and CSFV replicability resumed. Together, these data indicated that CSFV transformed from early endosome and late endosome into lysosome after endocytosis for further replication and that U18666A was a potential drug candidate for anti-pestivirus treatment.

Keywords

Antiviral activity; Cholesterol; Classical swine fever virus (CSFV); NPC1; U18666A.

Figures
Products